Canada Life’s Meridian Bioscience Inc VIVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-54,697
| Closed | -$1.82M | – | 2351 |
|
|
2022
Q4 | $1.82M | Buy |
54,697
+543
| +1% | +$17.5K | ﹤0.01% | 1275 |
|
|
2022
Q3 | $1.71M | Buy |
54,154
+11,059
| +26% | +$358K | ﹤0.01% | 1247 |
|
|
2022
Q2 | $1.31M | Buy |
43,095
+5,806
| +16% | +$157K | ﹤0.01% | 1367 |
|
|
2022
Q1 | $994K | Sell |
37,289
-802
| -2% | -$19.1K | ﹤0.01% | 1527 |
|
|
2021
Q4 | $776K | Hold |
38,091
| – | – | ﹤0.01% | 1602 |
|
|
2021
Q3 | $739K | Hold |
38,091
| – | – | ﹤0.01% | 1629 |
|
|
2021
Q2 | $844K | Buy |
38,091
+35
| +0.1% | +$742 | ﹤0.01% | 1592 |
|
|
2021
Q1 | $998K | Sell |
38,056
-3,658
| -9% | -$87K | ﹤0.01% | 1525 |
|
|
2020
Q4 | $780K | Sell |
41,714
-6,793
| -14% | -$127K | ﹤0.01% | 1610 |
|
|
2020
Q3 | $823K | Sell |
48,507
-4,664
| -9% | -$90.6K | ﹤0.01% | 1490 |
|
|
2020
Q2 | $1.24M | Buy |
53,171
+279
| +0.5% | +$4.04K | ﹤0.01% | 1325 |
|
|
2020
Q1 | $441K | Hold |
52,892
| – | – | ﹤0.01% | 1637 |
|
|
2019
Q4 | $512K | Buy |
+52,892
| New | +$497K | ﹤0.01% | 1706 |
|
|
2019
Q3 | – | Sell |
-56,124
| Closed | -$666K | – | 2486 |
|
|
2019
Q2 | $666K | Sell |
56,124
-929
| -2% | -$11.2K | ﹤0.01% | 1687 |
|
|
2019
Q1 | $1M | Hold |
57,053
| – | – | ﹤0.01% | 1381 |
|
|
2018
Q4 | $915K | Sell |
57,053
-830
| -1% | -$14.2K | ﹤0.01% | 1431 |
|
|
2018
Q3 | $859K | Buy |
57,883
+58
| +0.1% | +$899 | ﹤0.01% | 1581 |
|
|
2018
Q2 | $919K | Sell |
57,825
-16
| -0% | -$239 | ﹤0.01% | 1561 |
|
|
2018
Q1 | $821K | Buy |
57,841
+1,482
| +3% | +$21.9K | ﹤0.01% | 1579 |
|
|
2017
Q4 | $789K | Sell |
56,359
-4,929
| -8% | -$72.2K | ﹤0.01% | 1608 |
|
|
2017
Q3 | $867K | Hold |
61,288
| – | – | ﹤0.01% | 1561 |
|
|
2017
Q2 | $962K | Hold |
61,288
| – | – | ﹤0.01% | 1530 |
|
|
2017
Q1 | $842K | Buy |
61,288
+3,690
| +6% | +$51.6K | ﹤0.01% | 1565 |
|
|
2016
Q4 | $1.02M | Hold |
57,598
| – | – | ﹤0.01% | 1474 |
|
|
2016
Q3 | $1.11M | Hold |
57,598
| – | – | ﹤0.01% | 1396 |
|
|
2016
Q2 | $1.12M | Buy |
57,598
+51,473
| +840% | +$1.01M | ﹤0.01% | 1357 |
|
|
2016
Q1 | $126K | Hold |
6,125
| – | – | ﹤0.01% | 1626 |
|
|
2015
Q4 | $126K | Hold |
6,125
| – | – | ﹤0.01% | 1600 |
|
|
2015
Q3 | $105K | Hold |
6,125
| – | – | ﹤0.01% | 1666 |
|
|
2015
Q2 | $114K | Hold |
6,125
| – | – | ﹤0.01% | 1766 |
|
|
2015
Q1 | $116K | Hold |
6,125
| – | – | ﹤0.01% | 1709 |
|
|
2014
Q4 | $101K | Hold |
6,125
| – | – | ﹤0.01% | 1750 |
|
|
2014
Q3 | $109K | Buy |
6,125
+4,652
| +316% | +$91.4K | ﹤0.01% | 1616 |
|
|
2014
Q2 | $30K | Hold |
1,473
| – | – | ﹤0.01% | 2150 |
|
|
2014
Q1 | $32K | Hold |
1,473
| – | – | ﹤0.01% | 2015 |
|
|
2013
Q4 | $39K | Buy |
+1,473
| New | +$36.2K | ﹤0.01% | 1928 |
|
Other funds holding VIVO
Canada Life's VIVO Position: Q1 2023 in Review
Canada Life sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 54,697 shares — an estimated $1.82M sold.
Canada Life first reported a position in VIVO in Q4 2013 and held it in 36 quarters. The position peaked at $1.82M in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.
- Canada Life reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
- Canada Life sold 54,697 Meridian Bioscience Inc shares in Q1 2023, an estimated $1.82M.
- Canada Life first reported a position in Meridian Bioscience Inc in Q4 2013 and held it in 36 quarters.
- Canada Life's Meridian Bioscience Inc position peaked at $1.82M in Q4 2022.
- 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.
Based on Canada Life's 13F filing for Q1 2023, filed 12 May 2023.